Analyst Actions

HC Wainwright & Co. Reiterates Buy on GRI Bio, Maintains $10 Price Target

Sep 10, 2026 · 01:24 PM ET· updated 21h ago

HC Wainwright & Co. analyst Matthew Keller reiterates GRI Bio (NASDAQ:GRI) with a Buy and maintains $10 price target.

Why It Matters

A stock expert named Matthew Keller says he still likes GRI Bio and thinks it could reach $10 per share. When an expert keeps saying buy, it means they still believe in the company even after checking the latest news.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

GRI1.98

+0.04 (+2.06%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.